Healthcare Sector Stocks
The Healthcare sector has a total of 1046 stocks, with a combined market cap of $9.16 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 48.45.
Market Cap
9.16T
Revenue
4.67T
Profits
189.14B
PE Ratio
48.45
Profit Margin
4.05%
Dividend Yield
0.39%
1047 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.01T | -0.07% | 942,189 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 640.12B | -0.26% | 2,540,643 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 463.41B | 0.18% | 2,017,894 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 354.95B | -0.68% | 3,655,108 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 338.38B | -1.71% | 2,132,594 | 450.53B |
| 6 | NVS | Novartis AG | 264.17B | -0.14% | 1,629,805 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 254.11B | -0.18% | 1,608,719 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 235.38B | 3.75% | 1,468,509 | 46.34B |
| 9 | AMGN | Amgen Inc. | 204.48B | -0.86% | 1,307,090 | 38.10B |
| 10 | NVO | Novo Nordisk A/S | 191.47B | -1.96% | 5,225,299 | 50.34B |
| 11 | GILD | Gilead Sciences, Inc. | 180.97B | -0.31% | 1,980,662 | 30.46B |
| 12 | ABT | Abbott Laboratories | 177.16B | -0.69% | 3,480,038 | 46.59B |
| 13 | PFE | Pfizer Inc. | 157.08B | -0.58% | 20,762,429 | 63.70B |
| 14 | DHR | Danaher Corporation | 146.35B | 2.43% | 2,117,543 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 133.31B | -0.16% | 944,033 | 11.03B |
| 16 | BMY | Bristol-Myers Squibb Company | 130.26B | -0.51% | 4,296,570 | 49.19B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 130.24B | -1.09% | 329,145 | 12.59B |
| 18 | CVS | CVS Health Corporation | 121.11B | -0.90% | 2,681,673 | 412.65B |
| 19 | MDT | Medtronic plc | 120.30B | 0.27% | 3,569,320 | 37.54B |
| 20 | SYK | Stryker Corporation | 107.97B | -0.14% | 1,423,004 | 25.84B |
| 21 | MCK | McKesson Corporation | 104.70B | -1.42% | 313,981 | 410.98B |
| 22 | SNY | Sanofi | 102.64B | -1.64% | 1,600,970 | 55.89B |
| 23 | GSK | GSK plc | 100.17B | 0.08% | 1,560,215 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 91.81B | -0.34% | 557,692 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 91.32B | -0.75% | 799,953 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 77.76B | -1.90% | 213,935 | 15.53B |
| 27 | CI | The Cigna Group | 76.72B | 0.11% | 528,177 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 64.05B | -1.90% | 9,580,769 | 21.00B |
| 29 | ARGX | argenx SE | 62.63B | -0.34% | 119,570 | 5.32B |
| 30 | COR | Cencora, Inc. | 61.61B | -1.03% | 480,524 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 60.19B | 0.70% | 1,685,327 | 28.42B |
| 32 | MRNA | Moderna, Inc. | 57.59B | -1.66% | 4,682,162 | 2.23B |
| 33 | CAH | Cardinal Health, Inc. | 54.01B | -1.14% | 841,062 | 254.25B |
| 34 | BDX | Becton, Dickinson and Company | 50.71B | 1.79% | 938,274 | 22.48B |
| 35 | NTRA | Natera, Inc. | 50.24B | 1.98% | 1,353,760 | 2.71B |
| 36 | EW | Edwards Lifesciences Corporation | 49.38B | 0.18% | 1,687,484 | 6.51B |
| 37 | HUM | Humana Inc. | 47.79B | -2.22% | 401,505 | 145.68B |
| 38 | TEVA | Teva Pharmaceutical Industries Limited | 45.46B | 0.76% | 3,346,404 | 17.32B |
| 39 | IQV | IQVIA Holdings Inc. | 44.52B | 1.81% | 752,511 | 16.98B |
| 40 | VEEV | Veeva Systems Inc. | 43.79B | 1.80% | 720,025 | 3.46B |
| 41 | RVMD | Revolution Medicines, Inc. | 43.68B | -0.65% | 678,261 | - |
| 42 | A | Agilent Technologies, Inc. | 42.46B | 2.58% | 715,467 | 7.37B |
| 43 | MDLN | Medline Inc. | 42.32B | -1.23% | 4,115,959 | 29.94B |
| 44 | WAT | Waters Corporation | 41.29B | 2.50% | 352,030 | 4.64B |
| 45 | HLN | Haleon plc | 40.63B | -1.22% | 10,177,262 | 14.80B |
| 46 | IDXX | IDEXX Laboratories, Inc. | 40.26B | 0.28% | 283,752 | 4.55B |
| 47 | ONC | BeOne Medicines AG | 39.59B | -1.59% | 129,291 | 6.13B |
| 48 | ILMN | Illumina, Inc. | 34.18B | 8.70% | 1,828,873 | 4.49B |
| 49 | RPRX | Royalty Pharma plc | 33.57B | -1.12% | 1,203,046 | 2.54B |
| 50 | CNC | Centene Corporation | 33.47B | -2.39% | 1,340,597 | 180.30B |
| 51 | RMD | ResMed Inc. | 33.29B | 4.34% | 742,311 | 5.65B |
| 52 | DXCM | DexCom, Inc. | 32.94B | 3.07% | 2,212,539 | 4.97B |
| 53 | ALC | Alcon Inc. | 32.51B | 0.16% | 764,914 | 10.86B |
| 54 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.36B | -3.28% | 819,753 | 4.80B |
| 55 | BIIB | Biogen Inc. | 31.90B | -0.67% | 336,395 | 10.03B |
| 56 | ZTS | Zoetis Inc. | 30.29B | -0.52% | 2,161,175 | 9.53B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 28.93B | -0.31% | 2,333,032 | 21.27B |
| 58 | ROIV | Roivant Sciences Ltd. | 28.63B | -3.39% | 4,151,866 | 7.53M |
| 59 | DGX | Quest Diagnostics Incorporated | 27.30B | 3.96% | 740,931 | 11.56B |
| 60 | MTD | Mettler-Toledo International Inc. | 26.57B | 3.15% | 88,084 | 4.13B |
| 61 | LH | Labcorp Holdings Inc. | 26.38B | 3.15% | 455,365 | 14.35B |
| 62 | INSM | Insmed Incorporated | 26.07B | -4.72% | 1,374,984 | 1.14B |
| 63 | WST | West Pharmaceutical Services, Inc. | 25.89B | 3.58% | 453,564 | 3.33B |
| 64 | INCY | Incyte Corporation | 24.69B | -0.33% | 642,371 | 5.82B |
| 65 | BNTX | BioNTech SE | 24.46B | -1.51% | 357,076 | 3.03B |
| 66 | PHG | Koninklijke Philips N.V. | 24.43B | -0.68% | 441,143 | 20.18B |
| 67 | GH | Guardant Health, Inc. | 23.95B | 6.35% | 1,879,985 | 1.18B |
| 68 | UTHR | United Therapeutics Corporation | 21.48B | -0.39% | 211,578 | 3.15B |
| 69 | THC | Tenet Healthcare Corporation | 21.00B | -1.40% | 238,320 | 21.81B |
| 70 | STE | STERIS plc | 20.74B | -0.43% | 282,252 | 6.04B |
| 71 | GMAB | Genmab A/S | 19.84B | 4.53% | 2,030,611 | 4.13B |
| 72 | VTRS | Viatris Inc. | 19.07B | -0.36% | 2,877,421 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.78B | 1.99% | 1,006,882 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.29B | 4.05% | 118,076 | 2.78B |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 15.61B | -2.20% | 227,313 | 4.60B |
| 76 | SOLV | Solventum Corporation | 15.53B | 1.60% | 530,181 | 8.31B |
| 77 | RVTY | Revvity, Inc. | 15.51B | 8.21% | 1,482,444 | 2.91B |
| 78 | ASND | Ascendis Pharma A/S | 15.44B | -11.26% | 1,913,195 | 1.20B |
| 79 | NBIX | Neurocrine Biosciences, Inc. | 15.27B | -4.42% | 702,135 | 3.37B |
| 80 | EXEL | Exelixis, Inc. | 14.07B | 1.05% | 817,045 | 2.44B |
| 81 | SMMT | Summit Therapeutics Inc. | 13.83B | -5.86% | 3,828,128 | - |
| 82 | BBIO | BridgeBio Pharma, Inc. | 13.35B | -5.66% | 2,292,191 | 713.07M |
| 83 | ICLR | ICON Public Limited Company | 13.32B | 2.17% | 494,234 | 8.29B |
| 84 | CRL | Charles River Laboratories International, Inc. | 13.17B | 1.01% | 430,513 | 4.00B |
| 85 | PEN | Penumbra, Inc. | 12.55B | -0.36% | 317,649 | 1.50B |
| 86 | BMRN | BioMarin Pharmaceutical Inc. | 12.43B | -3.28% | 990,086 | 3.41B |
| 87 | BAX | Baxter International Inc. | 12.27B | -0.57% | 2,903,656 | 11.47B |
| 88 | BTSG | BrightSpring Health Services, Inc. | 12.26B | -2.41% | 635,763 | 14.37B |
| 89 | FMS | Fresenius Medical Care AG | 12.17B | 0.52% | 288,276 | 22.19B |
| 90 | DVA | DaVita Inc. | 12.15B | 0.62% | 269,870 | 14.01B |
| 91 | TEM | Tempus AI, Inc. | 12.14B | 8.18% | 4,608,237 | 1.43B |
| 92 | EHC | Encompass Health Corporation | 12.12B | 0.30% | 305,790 | 6.21B |
| 93 | HALO | Halozyme Therapeutics, Inc. | 12.11B | -1.11% | 492,655 | 1.66B |
| 94 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.94B | -4.28% | 143,062 | 1.28B |
| 95 | SNN | Smith & Nephew plc | 11.89B | -0.95% | 1,237,680 | 6.30B |
| 96 | CORT | Corcept Therapeutics Incorporated | 11.86B | -1.84% | 317,724 | 830.81M |
| 97 | ELAN | Elanco Animal Health Incorporated | 11.38B | -1.60% | 4,750,396 | 5.02B |
| 98 | TECH | Bio-Techne Corporation | 11.33B | - | 1,369,687 | 1.22B |
| 99 | AXSM | Axsome Therapeutics, Inc. | 10.87B | -4.15% | 298,883 | 776.57M |
| 100 | MOH | Molina Healthcare, Inc. | 10.87B | -2.56% | 178,630 | 42.47B |
| 101 | AVTR | Avantor, Inc. | 10.55B | 2.94% | 3,971,952 | 6.56B |
| 102 | ALGN | Align Technology, Inc. | 10.53B | -3.13% | 365,139 | 4.14B |
| 103 | UHS | Universal Health Services, Inc. | 10.43B | 2.16% | 347,587 | 18.11B |
| 104 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.24B | -10.13% | 2,485,023 | 669.50M |
| 105 | KRSA | Korsana Biosciences, Inc. | 10.19B | -0.41% | 77,397 | - |
| 106 | COO | The Cooper Companies, Inc. | 10.17B | -1.40% | 2,008,490 | 4.24B |
| 107 | BIO | Bio-Rad Laboratories, Inc. | 10.14B | 2.88% | 330,807 | 2.59B |
| 108 | GKOS | Glaukos Corporation | 10.11B | 0.24% | 188,252 | 612.84M |
| 109 | GMED | Globus Medical, Inc. | 10.07B | -1.02% | 897,183 | 3.14B |
| 110 | ENSG | The Ensign Group, Inc. | 10.05B | -0.62% | 180,563 | 5.49B |
| 111 | OSCR | Oscar Health, Inc. | 10.02B | -3.85% | 2,179,640 | 15.32B |
| 112 | ABVX | ABIVAX Société Anonyme | 10.02B | -5.72% | 1,409,048 | 5.67M |
| 113 | RDY | Dr. Reddy's Laboratories Limited | 9.98B | -2.60% | 1,642,327 | 3.50B |
| 114 | KRYS | Krystal Biotech, Inc. | 9.98B | -0.80% | 121,917 | 440.48M |
| 115 | RGEN | Repligen Corporation | 9.89B | 4.33% | 461,363 | 785.10M |
| 116 | HSIC | Henry Schein, Inc. | 9.77B | -1.40% | 383,673 | 13.60B |
| 117 | TXG | 10x Genomics, Inc. | 9.76B | 6.80% | 1,680,607 | 616.91M |
| 118 | PODD | Insulet Corporation | 9.63B | 0.81% | 739,760 | 3.05B |
| 119 | CYTK | Cytokinetics, Incorporated | 9.63B | -4.36% | 1,389,204 | 67.67M |
| 120 | KYMR | Kymera Therapeutics, Inc. | 9.40B | -1.39% | 286,576 | 105.00M |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 9.31B | -2.67% | 225,170 | 281.99M |
| 122 | QGEN | Qiagen N.V. | 8.86B | 2.32% | 842,751 | 2.10B |
| 123 | PRAX | Praxis Precision Medicines, Inc. | 8.81B | -4.50% | 99,943 | 7.46M |
| 124 | PCVX | Vaxcyte, Inc. | 8.77B | -1.06% | 1,018,327 | - |
| 125 | TWST | Twist Bioscience Corporation | 8.66B | 2.52% | 817,875 | 431.80M |
| 126 | BRKR | Bruker Corporation | 8.50B | 5.96% | 1,842,526 | 3.50B |
| 127 | IBRX | ImmunityBio, Inc. | 8.36B | -5.73% | 5,178,485 | 165.79M |
| 128 | HQY | HealthEquity, Inc. | 7.98B | 0.48% | 281,481 | 1.36B |
| 129 | CAI | Caris Life Sciences, Inc. | 7.94B | 7.87% | 6,063,696 | 989.61M |
| 130 | SYRE | Spyre Therapeutics, Inc. | 7.92B | -1.08% | 406,547 | - |
| 131 | ATR | AptarGroup, Inc. | 7.89B | -0.69% | 193,433 | 3.93B |
| 132 | IONS | Ionis Pharmaceuticals, Inc. | 7.86B | -8.07% | 3,636,480 | 874.09M |
| 133 | HNGE | Hinge Health, Inc. | 7.61B | -0.45% | 622,450 | 720.06M |
| 134 | ALKS | Alkermes plc | 7.59B | -1.22% | 800,193 | 1.67B |
| 135 | IMVT | Immunovant, Inc. | 7.56B | -2.79% | 611,512 | - |
| 136 | TGTX | TG Therapeutics, Inc. | 7.55B | -1.46% | 841,757 | 799.54M |
| 137 | BLTE | Belite Bio, Inc | 6.84B | -1.89% | 62,735 | - |
| 138 | PACS | PACS Group, Inc. | 6.75B | -4.31% | 380,263 | 5.55B |
| 139 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.71B | -4.80% | 381,926 | 239.92M |
| 140 | GRFS | Grifols, S.A. | 6.67B | -0.74% | 369,332 | 8.48B |
| 141 | HIMS | Hims & Hers Health, Inc. | 6.61B | -1.67% | 5,115,057 | 2.58B |
| 142 | CHE | Chemed Corporation | 6.60B | -1.42% | 73,383 | 2.60B |
| 143 | LNTH | Lantheus Holdings, Inc. | 6.57B | 0.33% | 644,626 | 1.56B |
| 144 | CGON | CG Oncology, Inc. | 6.51B | -0.43% | 309,896 | 6.23M |
| 145 | RDNT | RadNet, Inc. | 6.24B | 5.06% | 741,202 | 2.27B |
| 146 | MMED | MiniMed Group, Inc. | 6.21B | 0.46% | 1,436,941 | 3.22B |
| 147 | BLCO | Bausch + Lomb Corporation | 6.18B | -1.59% | 151,743 | 5.32B |
| 148 | MIRM | Mirum Pharmaceuticals, Inc. | 6.10B | -2.84% | 365,301 | 618.07M |
| 149 | ORKA | Oruka Therapeutics, Inc. | 6.06B | -4.58% | 424,034 | - |
| 150 | STVN | Stevanato Group S.p.A. | 5.93B | 1.83% | 167,592 | 1.40B |
| 151 | DNTH | Dianthus Therapeutics, Inc. | 5.86B | -2.69% | 234,012 | 1.90M |
| 152 | AMRX | Amneal Pharmaceuticals, Inc. | 5.85B | -2.38% | 536,489 | 3.12B |
| 153 | TVTX | Travere Therapeutics, Inc. | 5.84B | -5.85% | 1,165,092 | 591.33M |
| 154 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.83B | -2.39% | 232,768 | 840.85M |
| 155 | LQDA | Liquidia Corporation | 5.83B | -0.31% | 773,178 | 450.91M |
| 156 | SRRK | Scholar Rock Holding Corporation | 5.78B | -8.40% | 2,949,462 | - |
| 157 | COGT | Cogent Biosciences, Inc. | 5.73B | -1.17% | 967,681 | - |
| 158 | ERAS | Erasca, Inc. | 5.60B | -0.87% | 3,110,701 | - |
| 159 | XENE | Xenon Pharmaceuticals Inc. | 5.48B | -2.68% | 284,647 | 7.50M |
| 160 | PTCT | PTC Therapeutics, Inc. | 5.47B | -1.43% | 435,296 | 1.01B |
| 161 | TFX | Teleflex Incorporated | 5.47B | -0.98% | 394,777 | 2.25B |
| 162 | LGND | Ligand Pharmaceuticals Incorporated | 5.42B | -3.20% | 84,396 | 290.54M |
| 163 | SHC | Sotera Health Company | 5.41B | 2.32% | 774,027 | 1.22B |
| 164 | MMSI | Merit Medical Systems, Inc. | 5.13B | -1.29% | 190,376 | 1.58B |
| 165 | WAY | Waystar Holding Corp. | 5.11B | 6.97% | 3,989,286 | 1.21B |
| 166 | CRSP | CRISPR Therapeutics AG | 5.00B | -2.40% | 738,874 | 13.39M |
| 167 | DFTX | Definium Therapeutics, Inc. | 4.98B | -7.90% | 2,934,378 | - |
| 168 | LFST | LifeStance Health Group, Inc. | 4.94B | -3.36% | 3,807,557 | 1.58B |
| 169 | BLLN | BillionToOne, Inc. | 4.88B | 2.59% | 232,633 | 397.41M |
| 170 | HAE | Haemonetics Corporation | 4.81B | -0.45% | 177,276 | 1.35B |
| 171 | EWTX | Edgewise Therapeutics, Inc. | 4.74B | -2.24% | 900,814 | - |
| 172 | DOCS | Doximity, Inc. | 4.65B | -1.17% | 1,284,564 | 655.57M |
| 173 | ACAD | ACADIA Pharmaceuticals Inc. | 4.63B | -2.43% | 502,553 | 1.14B |
| 174 | CON | Concentra Group Holdings Parent, Inc. | 4.56B | -0.06% | 328,377 | 2.29B |
| 175 | PBLS | Parabilis Medicines, Inc. | 4.42B | -1.02% | 263,033 | 148.00K |
| 176 | LIVN | LivaNova PLC | 4.39B | -1.23% | 289,853 | 1.47B |
| 177 | TLX | Telix Pharmaceuticals Limited | 4.30B | 9.25% | 863,391 | 890.79M |
| 178 | ITGR | Integer Holdings Corporation | 4.29B | 0.12% | 225,189 | 1.84B |
| 179 | MANE | Veradermics, Incorporated | 4.27B | 0.54% | 535,172 | - |
| 180 | HTFL | HeartFlow, Inc. | 4.25B | -1.27% | 715,500 | 212.07M |
| 181 | ADPT | Adaptive Biotechnologies Corporation | 4.24B | 7.30% | 1,541,950 | 308.08M |
| 182 | IOVA | Iovance Biotherapeutics, Inc. | 4.18B | -0.32% | 6,337,283 | 324.97M |
| 183 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.14B | -1.87% | 704,393 | -665.00K |
| 184 | RLAY | Relay Therapeutics, Inc. | 4.13B | -1.10% | 1,618,782 | 10.35M |
| 185 | TNGX | Tango Therapeutics, Inc. | 4.05B | -2.20% | 805,658 | 53.81M |
| 186 | CELC | Celcuity Inc. | 4.02B | -1.76% | 402,468 | - |
| 187 | PLSE | Pulse Biosciences, Inc. | 4.01B | 3.71% | 259,667 | 1.19M |
| 188 | INDV | Indivior Pharmaceuticals, Inc. | 3.99B | -1.86% | 502,932 | 1.33B |
| 189 | NVST | Envista Holdings Corporation | 3.99B | -3.66% | 2,644,173 | 2.86B |
| 190 | ICUI | ICU Medical, Inc. | 3.92B | -0.43% | 82,999 | 2.16B |
| 191 | ELVN | Enliven Therapeutics, Inc. | 3.90B | -2.28% | 405,951 | - |
| 192 | IRTC | iRhythm Holdings, Inc. | 3.70B | -2.15% | 236,295 | 825.34M |
| 193 | ABCL | AbCellera Biologics Inc. | 3.68B | 1.79% | 2,685,028 | 66.17M |
| 194 | IDYA | IDEAYA Biosciences, Inc. | 3.63B | -1.21% | 317,054 | 234.13M |
| 195 | OGN | Organon & Co. | 3.59B | 0.18% | 453,208 | 6.13B |
| 196 | OPCH | Option Care Health, Inc. | 3.54B | -1.54% | 1,394,314 | 5.69B |
| 197 | NHC | National HealthCare Corporation | 3.51B | -1.58% | 25,751 | 1.56B |
| 198 | VKTX | Viking Therapeutics, Inc. | 3.50B | -4.85% | 1,874,661 | - |
| 199 | LEGN | Legend Biotech Corporation | 3.46B | -3.62% | 1,982,242 | 1.27B |
| 200 | TARS | Tarsus Pharmaceuticals, Inc. | 3.41B | -2.73% | 268,422 | 606.33M |
| 201 | DYN | Dyne Therapeutics, Inc. | 3.40B | -1.78% | 1,884,979 | - |
| 202 | GRAL | GRAIL, Inc. | 3.38B | 0.24% | 723,456 | 165.26M |
| 203 | DNLI | Denali Therapeutics Inc. | 3.28B | -3.39% | 971,050 | 3.60M |
| 204 | VCYT | Veracyte, Inc. | 3.21B | -3.13% | 805,878 | 561.90M |
| 205 | TMDX | TransMedics Group, Inc. | 3.10B | 4.23% | 526,761 | 668.47M |
| 206 | AVAH | Aveanna Healthcare Holdings Inc. | 3.08B | -1.70% | 2,348,443 | 2.60B |
| 207 | WRBY | Warby Parker Inc. | 3.05B | -4.12% | 1,499,478 | 911.61M |
| 208 | RCUS | Arcus Biosciences, Inc. | 3.04B | -0.66% | 876,896 | 117.00M |
| 209 | GRDN | Guardian Pharmacy Services, Inc. | 3.02B | 2.60% | 305,795 | 1.46B |
| 210 | QURE | uniQure N.V. | 3.00B | -3.72% | 558,719 | 18.67M |
| 211 | CLDX | Celldex Therapeutics, Inc. | 3.00B | -2.50% | 310,882 | 158.00K |
| 212 | ARQT | Arcutis Biotherapeutics, Inc. | 2.94B | -3.71% | 1,165,372 | 463.98M |
| 213 | MBX | MBX Biosciences, Inc. | 2.92B | 1.83% | 407,661 | - |
| 214 | WGS | GeneDx Holdings Corp. | 2.89B | 7.97% | 499,021 | 454.43M |
| 215 | ATRC | AtriCure, Inc. | 2.87B | 0.99% | 782,556 | 569.62M |
| 216 | BKD | Brookdale Senior Living Inc. | 2.80B | -1.51% | 1,718,776 | 2.93B |
| 217 | ZLAB | Zai Lab Limited | 2.80B | 1.38% | 461,498 | 449.61M |
| 218 | RGC | Regencell Bioscience Holdings Limited | 2.77B | -2.70% | 34,741 | - |
| 219 | CDNA | CareDx, Inc. | 2.77B | 2.12% | 447,325 | 458.09M |
| 220 | GPCR | Structure Therapeutics Inc. | 2.76B | 0.75% | 406,243 | - |
| 221 | IMNM | Immunome, Inc. | 2.72B | -2.32% | 423,004 | 4.02M |
| 222 | NEOG | Neogen Corporation | 2.69B | 3.18% | 1,640,142 | 870.40M |
| 223 | PHVS | Pharvaris N.V. | 2.68B | -1.84% | 796,061 | - |
| 224 | AXGN | Axogen, Inc. | 2.65B | 2.99% | 559,692 | 251.17M |
| 225 | PRVA | Privia Health Group, Inc. | 2.61B | -2.16% | 595,907 | 2.36B |
| 226 | ACHC | Acadia Healthcare Company, Inc. | 2.60B | -0.43% | 512,229 | 3.37B |
| 227 | IRON | Disc Medicine, Inc. | 2.57B | -2.76% | 356,522 | - |
| 228 | NAMS | NewAmsterdam Pharma Company N.V. | 2.56B | -4.20% | 761,851 | 7.12M |
| 229 | NRIX | Nurix Therapeutics, Inc. | 2.55B | -3.80% | 637,945 | 36.77M |
| 230 | MLYS | Mineralys Therapeutics, Inc. | 2.54B | -0.69% | 913,271 | - |
| 231 | PGEN | Precigen, Inc. | 2.50B | 1.75% | 1,402,465 | 85.72M |
| 232 | CLOV | Clover Health Investments, Corp. | 2.49B | -8.04% | 7,374,687 | 2.48B |
| 233 | NEO | NeoGenomics, Inc. | 2.45B | 3.64% | 1,578,767 | 766.30M |
| 234 | VRDN | Viridian Therapeutics, Inc. | 2.45B | -2.75% | 583,918 | 71.13M |
| 235 | HRMY | Harmony Biosciences Holdings, Inc. | 2.42B | 0.05% | 401,136 | 959.90M |
| 236 | VERA | Vera Therapeutics, Inc. | 2.40B | -2.17% | 9,010,541 | - |
| 237 | SUPN | Supernus Pharmaceuticals, Inc. | 2.38B | -1.23% | 383,608 | 830.44M |
| 238 | HCM | HUTCHMED (China) Limited | 2.33B | 0.52% | 52,332 | 549.12M |
| 239 | BEAM | Beam Therapeutics Inc. | 2.32B | -3.85% | 935,653 | 156.04M |
| 240 | OCUL | Ocular Therapeutix, Inc. | 2.28B | -3.36% | 773,408 | 52.06M |
| 241 | SLS | SELLAS Life Sciences Group, Inc. | 2.27B | -3.97% | 3,566,780 | - |
| 242 | NKTR | Nektar Therapeutics | 2.26B | -3.47% | 431,634 | 54.59M |
| 243 | PBH | Prestige Consumer Healthcare Inc. | 2.23B | -0.94% | 320,927 | 1.10B |
| 244 | SRPT | Sarepta Therapeutics, Inc. | 2.21B | -0.10% | 1,091,044 | 1.97B |
| 245 | TRLV | Trulieve Cannabis Corp. | 2.21B | -1.38% | 1,128,218 | 1.14B |
| 246 | PVLA | Palvella Therapeutics, Inc. | 2.17B | -0.54% | 151,474 | - |
| 247 | INSP | Inspire Medical Systems, Inc. | 2.17B | 0.87% | 400,070 | 898.74M |
| 248 | TRVI | Trevi Therapeutics, Inc. | 2.15B | -4.91% | 1,400,095 | - |
| 249 | UFPT | UFP Technologies, Inc. | 2.15B | -0.30% | 74,057 | 631.64M |
| 250 | ESTA | Establishment Labs Holdings Inc. | 2.14B | -0.19% | 80,634 | 245.82M |
| 251 | AUPH | Aurinia Pharmaceuticals Inc. | 2.14B | -2.07% | 469,870 | 311.51M |
| 252 | PGNY | Progyny, Inc. | 2.14B | - | 310,023 | 1.31B |
| 253 | BHC | Bausch Health Companies Inc. | 2.13B | -3.89% | 874,911 | 10.85B |
| 254 | MD | Pediatrix Medical Group, Inc. | 2.13B | -0.33% | 310,722 | 1.95B |
| 255 | ALHC | Alignment Healthcare, Inc. | 2.12B | -21.17% | 15,656,813 | 4.58B |
| 256 | ADUS | Addus HomeCare Corporation | 2.11B | -1.92% | 142,097 | 1.48B |
| 257 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.07B | -1.58% | 2,411,008 | 940.61M |
| 258 | KOD | Kodiak Sciences Inc. | 2.07B | -0.45% | 402,217 | - |
| 259 | BFLY | Butterfly Network, Inc. | 2.07B | 4.86% | 5,081,397 | 112.14M |
| 260 | GENB | Generate Biomedicines, Inc. | 2.07B | 0.63% | 577,664 | 26.48M |
| 261 | RAPP | Rapport Therapeutics, Inc. | 2.05B | -3.06% | 87,761 | 20.00M |
| 262 | VCEL | Vericel Corporation | 2.04B | 0.73% | 227,943 | 306.30M |
| 263 | URGN | UroGen Pharma Ltd. | 2.03B | -2.56% | 244,918 | 188.73M |
| 264 | ZBIO | Zenas BioPharma, Inc. | 2.02B | -2.79% | 443,736 | 1.00M |
| 265 | ALMR | Alamar Biosciences, Inc. | 2.01B | 3.25% | 232,620 | 100.42M |
| 266 | NUVB | Nuvation Bio Inc. | 2.00B | -4.04% | 4,746,952 | 169.90M |
| 267 | XRAY | DENTSPLY SIRONA Inc. | 1.99B | -3.66% | 2,083,725 | 3.64B |
| 268 | ASTH | Astrana Health, Inc. | 1.98B | -2.40% | 127,249 | 3.84B |
| 269 | AGIO | Agios Pharmaceuticals, Inc. | 1.97B | -0.78% | 599,949 | 98.34M |
| 270 | ADMA | ADMA Biologics, Inc. | 1.96B | -4.05% | 1,581,273 | 512.28M |
| 271 | CMPS | COMPASS Pathways plc | 1.92B | -4.85% | 1,404,975 | - |
| 272 | PRGO | Perrigo Company plc | 1.91B | 0.81% | 776,060 | 4.14B |
| 273 | MESO | Mesoblast Limited | 1.91B | -1.93% | 122,577 | 120.25M |
| 274 | NVCR | NovoCure Limited | 1.91B | 0.92% | 355,810 | 699.19M |
| 275 | COAG | Hemab Therapeutics Holdings, Inc. | 1.87B | -1.06% | 136,901 | - |
| 276 | GHRS | GH Research PLC | 1.86B | -2.60% | 52,590 | - |
| 277 | SNDA | Sonida Senior Living, Inc. | 1.86B | -1.18% | 155,307 | 481.07M |
| 278 | SEPN | Septerna, Inc. | 1.84B | -0.18% | 123,096 | 98.88M |
| 279 | ZYME | Zymeworks Inc. | 1.84B | -3.61% | 210,431 | 37.13M |
| 280 | BHVN | Biohaven Ltd. | 1.84B | -3.88% | 1,670,842 | - |
| 281 | LMAT | LeMaitre Vascular, Inc. | 1.83B | -0.69% | 149,229 | 262.43M |
| 282 | NBTX | Nanobiotix S.A. | 1.82B | -0.90% | 118,199 | 38.27M |
| 283 | STOK | Stoke Therapeutics, Inc. | 1.82B | -4.76% | 769,201 | 27.59M |
| 284 | FTRE | Fortrea Holdings Inc. | 1.82B | 9.76% | 848,305 | 2.68B |
| 285 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.81B | 4.41% | 985,964 | 208.78M |
| 286 | SGRY | Surgery Partners, Inc. | 1.80B | -1.42% | 933,099 | 3.37B |
| 287 | ALVO | Alvotech | 1.79B | -0.50% | 430,874 | 494.61M |
| 288 | BLFS | BioLife Solutions, Inc. | 1.78B | 2.91% | 510,856 | 106.69M |
| 289 | KARD | Kardigan, Inc. | 1.77B | -0.68% | 182,737 | - |
| 290 | VIR | Vir Biotechnology, Inc. | 1.77B | -2.93% | 1,486,448 | 303.23M |
| 291 | TYRA | Tyra Biosciences, Inc. | 1.76B | 2.03% | 623,522 | - |
| 292 | XNCR | Xencor, Inc. | 1.76B | -3.67% | 553,593 | 104.97M |
| 293 | LKFT | Lakefront Biotherapeutics NV | 1.75B | 4.49% | 759,858 | 1.13B |
| 294 | KLRA | Kailera Therapeutics, Inc. | 1.75B | -1.75% | 431,089 | - |
| 295 | RXRX | Recursion Pharmaceuticals, Inc. | 1.75B | -4.40% | 7,940,207 | 54.86M |
| 296 | PSNL | Personalis, Inc. | 1.71B | -1.60% | 1,273,206 | 69.67M |
| 297 | SDGR | Schrödinger, Inc. | 1.71B | 9.88% | 2,150,584 | 259.04M |
| 298 | BRVE | Braveheart Bio, Inc. | 1.70B | -1.74% | 122,851 | - |
| 299 | ATEC | Alphatec Holdings, Inc. | 1.67B | -0.28% | 979,677 | 815.05M |
| 300 | TSHA | Taysha Gene Therapies, Inc. | 1.65B | 1.20% | 1,408,367 | 5.49M |
| 301 | IMCR | Immunocore Holdings plc | 1.63B | -2.50% | 191,105 | 430.78M |
| 302 | ANAB | AnaptysBio, Inc. | 1.62B | 1.27% | 191,805 | 232.39M |
| 303 | SNDX | Syndax Pharmaceuticals, Inc. | 1.60B | -2.29% | 535,155 | 252.25M |
| 304 | NTLA | Intellia Therapeutics, Inc. | 1.60B | -4.04% | 2,307,744 | 59.51M |
| 305 | INBX | Inhibrx Biosciences, Inc. | 1.57B | -3.33% | 108,198 | 1.30M |
| 306 | ETON | Eton Pharmaceuticals, Inc. | 1.57B | -4.70% | 233,047 | 105.60M |
| 307 | FRNM | Freenome, Inc. | 1.57B | -2.54% | 254,899 | 35.41M |
| 308 | AGL | agilon health, inc. | 1.55B | -0.02% | 102,696 | 5.92B |
| 309 | DMRA | Damora Therapeutics, Inc. | 1.54B | -11.94% | 1,028,113 | - |
| 310 | NVAX | Novavax, Inc. | 1.54B | -2.45% | 2,058,227 | 413.80M |
| 311 | ANIP | ANI Pharmaceuticals, Inc. | 1.53B | 1.38% | 134,549 | 978.38M |
| 312 | LTGO | Latigo Biotherapeutics, Inc. | 1.52B | 1.48% | 133,727 | - |
| 313 | ARDT | Ardent Health, Inc. | 1.52B | -2.00% | 212,002 | 6.41B |
| 314 | BCAX | Bicara Therapeutics Inc. | 1.50B | -2.03% | 368,232 | - |
| 315 | HCSG | Healthcare Services Group, Inc. | 1.50B | -0.59% | 151,518 | 1.86B |
| 316 | INVA | Innoviva, Inc. | 1.50B | -0.48% | 199,648 | 440.00M |
| 317 | OMCL | Omnicell, Inc. | 1.49B | -2.39% | 277,011 | 1.25B |
| 318 | AVLN | Avalyn Pharma Inc. | 1.49B | -4.20% | 78,952 | - |
| 319 | KMTS | Kestra Medical Technologies, Ltd. | 1.48B | 3.16% | 632,373 | 106.73M |
| 320 | NUTX | Nutex Health Inc. | 1.47B | -1.28% | 70,118 | 846.72M |
| 321 | INNV | InnovAge Holding Corp. | 1.47B | -0.28% | 83,454 | 989.71M |
| 322 | AZTA | Azenta, Inc. | 1.46B | 4.12% | 316,955 | 613.81M |
| 323 | AAPG | Ascentage Pharma Group International | 1.46B | -4.27% | 4,057 | 94.61M |
| 324 | PAHC | Phibro Animal Health Corporation | 1.43B | -2.20% | 140,762 | 1.52B |
| 325 | CNMD | CONMED Corporation | 1.41B | 1.37% | 131,708 | 1.37B |
| 326 | LBRX | LB Pharmaceuticals Inc | 1.40B | -3.01% | 201,419 | - |
| 327 | AVBP | ArriVent BioPharma, Inc. | 1.39B | -1.23% | 135,521 | - |
| 328 | TRAX | First Tracks Biotherapeutics, Inc. | 1.39B | 3.46% | 269,738 | - |
| 329 | PNTG | The Pennant Group, Inc. | 1.39B | -0.95% | 71,781 | 1.10B |
| 330 | MAZE | Maze Therapeutics, Inc. | 1.36B | -0.77% | 249,543 | 20.00M |
| 331 | ABSI | Absci Corporation | 1.36B | -2.22% | 1,393,782 | 1.56M |
| 332 | XERS | Xeris Biopharma Holdings, Inc. | 1.35B | -1.98% | 532,153 | 335.41M |
| 333 | DRTS | Alpha Tau Medical Ltd. | 1.34B | 1.11% | 206,546 | - |
| 334 | SVRA | Savara Inc. | 1.33B | -1.87% | 800,564 | - |
| 335 | VOR | Vor Biopharma Inc. | 1.33B | -2.56% | 401,315 | - |
| 336 | AMN | AMN Healthcare Services, Inc. | 1.33B | 0.32% | 136,077 | 3.43B |
| 337 | CGEM | Cullinan Therapeutics, Inc. | 1.33B | 1.03% | 599,787 | - |
| 338 | SPTX | Seaport Therapeutics, Inc. | 1.29B | -2.29% | 73,585 | - |
| 339 | RARE | Ultragenyx Pharmaceutical Inc. | 1.29B | -3.82% | 2,325,158 | 717.00M |
| 340 | ORIC | ORIC Pharmaceuticals, Inc. | 1.26B | -3.56% | 752,734 | - |
| 341 | CERT | Certara, Inc. | 1.26B | 3.62% | 795,671 | 421.75M |
| 342 | HROW | Harrow, Inc. | 1.25B | -1.85% | 288,790 | 275.59M |
| 343 | AKTS | Aktis Oncology, Inc. | 1.25B | -3.00% | 170,006 | 10.06M |
| 344 | AORT | Artivion, Inc. | 1.24B | 2.24% | 439,316 | 471.47M |
| 345 | IART | Integra LifeSciences Holdings Corporation | 1.23B | 0.86% | 408,680 | 1.65B |
| 346 | USPH | U.S. Physical Therapy, Inc. | 1.23B | 2.45% | 131,623 | 804.27M |
| 347 | OMER | Omeros Corporation | 1.22B | -3.09% | 1,015,982 | 38.42M |
| 348 | OMDA | Omada Health, Inc. | 1.22B | -2.88% | 492,386 | 309.76M |
| 349 | REPL | Replimune Group, Inc. | 1.21B | -1.68% | 1,367,652 | - |
| 350 | MGTX | MeiraGTx Holdings plc | 1.21B | -2.17% | 504,690 | 397.50M |
| 351 | TDOC | Teladoc Health, Inc. | 1.21B | 2.46% | 1,880,331 | 2.49B |
| 352 | GDRX | GoodRx Holdings, Inc. | 1.21B | -0.70% | 400,421 | 785.23M |
| 353 | CRON | Cronos Group Inc. | 1.20B | -1.08% | 377,613 | 179.09M |
| 354 | ANRO | Alto Neuroscience, Inc. | 1.20B | -3.85% | 188,997 | - |
| 355 | IMTX | Immatics N.V. | 1.17B | -0.35% | 185,372 | 47.65M |
| 356 | OPK | OPKO Health, Inc. | 1.17B | 0.64% | 968,744 | 587.90M |
| 357 | PRCT | PROCEPT BioRobotics Corporation | 1.17B | -3.00% | 806,560 | 337.34M |
| 358 | MNKD | MannKind Corporation | 1.15B | -4.53% | 1,892,111 | 393.63M |
| 359 | TNDM | Tandem Diabetes Care, Inc. | 1.15B | -1.67% | 862,453 | 1.04B |
| 360 | LMRI | Lumexa Imaging Holdings, Inc. | 1.14B | 3.86% | 133,343 | 1.04B |
| 361 | STAA | STAAR Surgical Company | 1.13B | -2.25% | 365,146 | 339.59M |
| 362 | GLUE | Monte Rosa Therapeutics, Inc. | 1.12B | -5.54% | 580,362 | 28.73M |
| 363 | OBX | Obsidian Therapeutics, Inc. | 1.12B | 0.11% | 261,463 | - |
| 364 | ATTO | Attovia Therapeutics, Inc. | 1.11B | -0.77% | 120,613 | 1.80M |
| 365 | ODTX | Odyssey Therapeutics, Inc. | 1.10B | -5.56% | 154,905 | 99.00K |
| 366 | JBIO | Jade Biosciences, Inc. | 1.09B | -5.34% | 321,308 | - |
| 367 | CRVS | Corvus Pharmaceuticals, Inc. | 1.09B | -0.84% | 798,750 | - |
| 368 | BVS | Bioventus Inc. | 1.09B | -1.52% | 188,925 | 581.85M |
| 369 | ALMS | Alumis Inc. | 1.09B | -9.06% | 2,604,472 | 7.40M |
| 370 | SLBT | SL Science Holding Limited | 1.08B | -8.21% | 54,419 | 3.27M |
| 371 | CSTL | Castle Biosciences, Inc. | 1.08B | 5.80% | 184,733 | 357.28M |
| 372 | IRMD | IRADIMED CORPORATION | 1.06B | 0.47% | 46,472 | 86.34M |
| 373 | APMD | Apnimed, Inc. | 1.05B | -0.98% | 213,250 | 115.12M |
| 374 | ENOV | Enovis Corporation | 1.05B | -0.16% | 1,389,442 | 2.30B |
| 375 | MLTX | MoonLake Immunotherapeutics | 1.03B | -4.18% | 1,116,265 | - |
| 376 | JANX | Janux Therapeutics, Inc. | 1.02B | -3.76% | 433,146 | 24.00M |
| 377 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.01B | -0.38% | 128,507 | 730.02M |
| 378 | KURA | Kura Oncology, Inc. | 1.00B | -2.51% | 1,092,901 | 77.23M |
| 379 | ABUS | Arbutus Biopharma Corporation | 999.13M | -1.56% | 2,283,495 | 181.72M |
| 380 | GMRS | GMR Solutions Inc. | 988.62M | -4.07% | 1,015,781 | 5.88B |
| 381 | HELP | Cybin Inc. | 983.39M | -1.10% | 833,283 | - |
| 382 | ANL | Adlai Nortye Group Ltd. | 965.33M | -5.90% | 114,950 | 18.06M |
| 383 | SGP | SpyGlass Pharma, Inc. | 960.46M | 0.19% | 97,775 | - |
| 384 | CBLL | CeriBell, Inc. | 956.87M | 2.48% | 105,657 | 101.96M |
| 385 | PCRX | Pacira BioSciences, Inc. | 944.33M | -4.01% | 297,036 | 746.16M |
| 386 | SANA | Sana Biotechnology, Inc. | 939.99M | -1.88% | 1,314,664 | - |
| 387 | IVA | Inventiva S.A. | 936.99M | -2.96% | 1,736,168 | 7.94M |
| 388 | FTH | Faeth Therapeutics, Inc. | 923.80M | -8.54% | 128,667 | - |
| 389 | SLDB | Solid Biosciences Inc. | 901.76M | -3.78% | 721,945 | - |
| 390 | WVE | Wave Life Sciences, Inc. | 888.69M | -1.53% | 1,264,437 | 65.37M |
| 391 | TBPH | Theravance Biopharma, Inc. | 884.18M | - | 182,826 | 104.31M |
| 392 | OLMA | Olema Pharmaceuticals, Inc. | 881.98M | -2.04% | 724,289 | - |
| 393 | HSTM | HealthStream, Inc. | 867.55M | 0.13% | 60,852 | 321.12M |
| 394 | IMMX | Immix Biopharma, Inc. | 864.19M | -1.06% | 555,662 | - |
| 395 | BBNX | Beta Bionics, Inc. | 858.40M | 14.05% | 956,905 | 119.01M |
| 396 | RIGL | Rigel Pharmaceuticals, Inc. | 858.15M | 1.30% | 87,524 | 276.79M |
| 397 | INMD | InMode Ltd. | 856.75M | 0.10% | 174,026 | 374.63M |
| 398 | LXRX | Lexicon Pharmaceuticals, Inc. | 854.32M | -3.03% | 1,242,452 | 41.47M |
| 399 | ARDX | Ardelyx, Inc. | 849.73M | -3.12% | 3,194,693 | 450.89M |
| 400 | SIBN | SI-BONE, Inc. | 846.62M | 1.02% | 193,188 | 213.60M |
| 401 | GERN | Geron Corporation | 844.85M | -4.01% | 5,047,403 | 204.56M |
| 402 | AVTX | Avalo Therapeutics, Inc. | 838.24M | -3.40% | 580,125 | 59.00K |
| 403 | CADL | Candel Therapeutics, Inc. | 834.82M | 2.20% | 519,816 | - |
| 404 | AVR | Anteris Technologies Global Corp. | 823.52M | -3.10% | 298,883 | 2.24M |
| 405 | CBIO | Crescent Biopharma, Inc. | 817.07M | -3.00% | 178,480 | 11.88M |
| 406 | ACRS | Aclaris Therapeutics, Inc. | 814.75M | -1.86% | 743,317 | 8.22M |
| 407 | CLYM | Climb Bio, Inc. | 784.58M | -6.18% | 882,093 | - |
| 408 | DSGN | Design Therapeutics, Inc. | 779.77M | -7.84% | 721,736 | - |
| 409 | VREX | Varex Imaging Corporation | 779.10M | 0.14% | 220,420 | 865.00M |
| 410 | AHCO | AdaptHealth Corp. | 774.44M | -1.28% | 758,802 | 3.36B |
| 411 | GLAS | Glass House Brands Inc. | 768.08M | 0.62% | 465,943 | 176.98M |
| 412 | SLN | Silence Therapeutics plc | 754.42M | -4.06% | 644,000 | 615.00K |
| 413 | ACHV | Achieve Life Sciences, Inc. | 749.13M | 0.69% | 747,424 | - |
| 414 | FDMT | 4D Molecular Therapeutics, Inc. | 748.56M | -1.53% | 279,155 | 92.01M |
| 415 | QDEL | QuidelOrtho Corporation | 746.79M | -2.07% | 1,324,749 | 2.67B |
| 416 | PHAR | Pharming Group N.V. | 743.57M | -2.96% | 10,021 | 366.48M |
| 417 | ANNX | Annexon, Inc. | 734.62M | -1.90% | 1,333,065 | - |
| 418 | NVCT | Nuvectis Pharma, Inc. | 720.54M | -5.29% | 90,981 | - |
| 419 | COLL | Collegium Pharmaceutical, Inc. | 713.94M | -3.86% | 427,005 | 808.21M |
| 420 | DBVT | DBV Technologies S.A. | 707.16M | -4.09% | 130,413 | 5.04M |
| 421 | GYRE | Gyre Therapeutics, Inc. | 700.88M | -1.20% | 66,284 | 109.82M |
| 422 | MNPR | Monopar Therapeutics Inc. | 698.60M | -3.91% | 53,800 | - |
| 423 | AURA | Aura Biosciences, Inc. | 696.90M | -4.14% | 310,881 | - |
| 424 | MDXG | MiMedx Group, Inc. | 696.74M | 3.02% | 614,919 | 355.17M |
| 425 | ZVRA | Zevra Therapeutics, Inc. | 694.20M | -2.99% | 374,098 | 136.07M |
| 426 | MPLT | MapLight Therapeutics, Inc. | 690.25M | -5.55% | 146,238 | - |
| 427 | AHG | Akso Health Group | 689.56M | 0.39% | 1,923 | 13.83M |
| 428 | BLSM | BlossomHill Therapeutics, Inc. | 686.11M | 2.99% | 80,824 | - |
| 429 | NGNE | Neurogene Inc. | 682.29M | -3.17% | 55,162 | 925.00K |
| 430 | IRWD | Ironwood Pharmaceuticals, Inc. | 677.48M | -1.68% | 533,159 | 389.32M |
| 431 | VSTM | Verastem, Inc. | 669.26M | -1.60% | 1,225,769 | 87.53M |
| 432 | SOPH | SOPHiA GENETICS SA | 669.10M | - | 1,516,388 | 86.17M |
| 433 | SSII | SS Innovations International, Inc. | 665.28M | -1.92% | 28,462 | 52.40M |
| 434 | PHAT | Phathom Pharmaceuticals, Inc. | 655.30M | -4.95% | 648,391 | 239.66M |
| 435 | STLN | Starling Oncology, Inc. | 651.24M | -1.99% | 761,490 | 587.24M |
| 436 | SGMT | Sagimet Biosciences Inc. | 647.07M | -4.32% | 484,773 | - |
| 437 | ANGO | AngioDynamics, Inc. | 646.44M | 0.84% | 249,678 | 320.17M |
| 438 | PHR | Phreesia, Inc. | 644.30M | -0.38% | 277,846 | 507.79M |
| 439 | OABI | OmniAb, Inc. | 638.26M | -2.01% | 384,621 | 38.46M |
| 440 | CTKB | Cytek Biosciences, Inc. | 636.92M | 1.45% | 690,398 | 206.71M |
| 441 | ALT | Altimmune, Inc. | 635.10M | -1.06% | 1,438,084 | 31.00K |
| 442 | DRUG | Bright Minds Biosciences Inc. | 631.27M | -6.09% | 22,466 | - |
| 443 | VALN | Valneva SE | 629.46M | -0.60% | 14,022 | 163.30M |
| 444 | OCS | Oculis Holding AG | 620.41M | -5.19% | 91,505 | 1.45M |
| 445 | CTEV | Claritev Corporation | 610.87M | -1.08% | 76,951 | 994.67M |
| 446 | KIDS | OrthoPediatrics Corp. | 610.71M | 4.70% | 99,496 | 252.72M |
| 447 | CRMD | CorMedix Inc. | 606.02M | -1.46% | 328,682 | 462.25M |
| 448 | AQST | Aquestive Therapeutics, Inc. | 604.97M | -1.23% | 963,378 | 54.09M |
| 449 | CTMX | CytomX Therapeutics, Inc. | 603.58M | -13.44% | 4,228,838 | 18.30M |
| 450 | STTK | Shattuck Labs, Inc. | 601.18M | -3.39% | 379,787 | 1.00M |
| 451 | SCTX | Scribe Therapeutics Inc. | 599.19M | 7.58% | 90,657 | 33.30M |
| 452 | ALLO | Allogene Therapeutics, Inc. | 597.70M | -2.81% | 1,860,737 | 4.64M |
| 453 | WEAV | Weave Communications, Inc. | 586.79M | 0.20% | 980,719 | 257.79M |
| 454 | EVO | Evotec SE | 586.69M | -3.87% | 68,025 | 819.47M |
| 455 | FLGT | Fulgent Genetics, Inc. | 580.30M | 2.13% | 228,133 | 323.93M |
| 456 | AGMB | AgomAb Therapeutics NV | 572.38M | -5.35% | 93,658 | - |
| 457 | PRME | Prime Medicine, Inc. | 569.29M | 0.63% | 1,781,343 | 4.07M |
| 458 | DCTH | Delcath Systems, Inc. | 561.08M | -1.64% | 130,613 | 95.42M |
| 459 | TECX | Tectonic Therapeutic, Inc. | 554.62M | -4.51% | 129,338 | - |
| 460 | TLRY | Tilray Brands, Inc. | 550.71M | -2.90% | 1,938,136 | 915.45M |
| 461 | EIKN | Eikon Therapeutics, Inc. | 549.78M | 8.44% | 440,716 | - |
| 462 | ARVN | Arvinas, Inc. | 547.94M | -0.24% | 398,754 | 316.70M |
| 463 | ASMB | Assembly Biosciences, Inc. | 540.39M | -8.35% | 260,698 | 74.85M |
| 464 | BWAY | BrainsWay Ltd. | 531.26M | -3.52% | 45,673 | 60.70M |
| 465 | EPRX | Eupraxia Pharmaceuticals Inc. | 530.90M | - | 122,724 | - |
| 466 | OVID | Ovid Therapeutics Inc. | 526.33M | -1.64% | 556,978 | 1.58M |
| 467 | PROK | ProKidney Corp. | 526.04M | -3.87% | 861,037 | 818.00K |
| 468 | RGNX | REGENXBIO Inc. | 518.20M | -9.67% | 716,334 | 174.48M |
| 469 | EOLS | Evolus, Inc. | 512.55M | -2.14% | 273,360 | 316.49M |
| 470 | CERS | Cerus Corporation | 510.87M | -0.59% | 458,036 | 221.55M |
| 471 | TCMD | Tactile Systems Technology, Inc. | 510.13M | -0.22% | 69,730 | 350.31M |
| 472 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 473 | AUTL | Autolus Therapeutics plc | 504.06M | -2.38% | 554,464 | 117.39M |
| 474 | CTNM | Contineum Therapeutics, Inc. | 501.11M | -10.12% | 385,182 | - |
| 475 | CAPR | Capricor Therapeutics, Inc. | 500.29M | -2.33% | 1,269,472 | 11.13M |
| 476 | NRC | NRC Health | 489.95M | -0.72% | 62,521 | 140.00M |
| 477 | INDP | Indaptus Therapeutics, Inc. | 489.00M | 16.88% | 1,670,252 | - |
| 478 | NPCE | NeuroPace, Inc. | 488.95M | -2.36% | 49,445 | 106.99M |
| 479 | ENTX | Entera Bio Ltd. | 488.26M | - | 333,823 | 42.00K |
| 480 | IRD | Opus Genetics, Inc. | 484.62M | -2.43% | 1,013,726 | 9.86M |
| 481 | PBYI | Puma Biotechnology, Inc. | 483.68M | 2.52% | 171,726 | 231.24M |
| 482 | DNA | Ginkgo Bioworks Holdings, Inc. | 476.77M | 1.00% | 435,277 | 132.42M |
| 483 | RLMD | Relmada Therapeutics, Inc. | 474.68M | 0.23% | 1,384,315 | - |
| 484 | KMDA | Kamada Ltd. | 474.40M | -2.41% | 67,508 | 191.85M |
| 485 | SENS | Senseonics Holdings, Inc. | 468.99M | 0.34% | 188,230 | 48.55M |
| 486 | ZURA | Zura Bio Limited | 467.65M | -6.33% | 1,670,592 | - |
| 487 | SRTA | Strata Critical Medical, Inc. | 466.66M | -1.59% | 279,588 | 255.98M |
| 488 | PRLD | Prelude Therapeutics Incorporated | 456.27M | -3.49% | 148,704 | 22.42M |
| 489 | VOGX | Vogenx, Inc. | 450.93M | -0.06% | 111,607 | - |
| 490 | SGHT | Sight Sciences, Inc. | 450.62M | 0.62% | 33,217 | 83.38M |
| 491 | ARCT | Arcturus Therapeutics Holdings Inc. | 449.08M | 3.34% | 229,670 | 29.37M |
| 492 | CABA | Cabaletta Bio, Inc. | 444.21M | -9.97% | 4,561,758 | - |
| 493 | ARTV | Artiva Biotherapeutics, Inc. | 441.97M | -10.85% | 333,604 | 251.00K |
| 494 | EVH | Evolent Health, Inc. | 436.41M | -5.85% | 1,065,048 | 2.10B |
| 495 | RZLT | Rezolute, Inc. | 433.54M | -2.35% | 396,530 | - |
| 496 | PRTA | Prothena Corporation plc | 431.23M | -5.19% | 138,657 | 54.53M |
| 497 | KYTX | Kyverna Therapeutics, Inc. | 427.34M | -6.62% | 764,647 | - |
| 498 | SPRY | ARS Pharmaceuticals, Inc. | 425.63M | -4.89% | 1,658,805 | 116.93M |
| 499 | PACB | Pacific Biosciences of California, Inc. | 424.28M | 1.11% | 3,889,396 | 159.27M |
| 500 | AVIR | Atea Pharmaceuticals, Inc. | 419.07M | -1.79% | 109,840 | - |